Skip to main navigation Skip to search Skip to main content

Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report

  • Chang Gung University

Research output: Contribution to journalJournal Article peer-review

4 Scopus citations
Original languageEnglish
Article numbere2200528
Pages (from-to)e2200528
JournalJCO precision oncology
Volume7
DOIs
StatePublished - 01 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cyclin-Dependent Kinase 4/genetics
  • Humans
  • Proto-Oncogene Proteins c-mdm2
  • Pyrazoles
  • Pyrimidines
  • Sarcoma/drug therapy
  • Tropomyosin

Cite this